Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Automated insulin delivery tech helps T1D runners manage glucose during marathons, enhancing safety and performance.
OpenAI launches AI models with advanced reasoning, improving problem-solving in science, coding, and math.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
AI in education can remove tedious tasks, enabling teachers to focus on human interaction. Lawmakers are making this happen.
AbCellera Biologics Inc. progresses with their TCE platform and strategic partnerships, aiming for CTA submissions in Q2 2025.
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.